Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Autori principali: | Jayne, DR, Rasmussen, N |
---|---|
Natura: | Journal article |
Lingua: | English |
Pubblicazione: |
1997
|
Documenti analoghi
Documenti analoghi
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
di: Mukhtyar, C, et al.
Pubblicazione: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
di: Rohini Handa
Pubblicazione: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
di: John Chuan Nguyen Tran, et al.
Pubblicazione: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
di: Flossmann, O, et al.
Pubblicazione: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
di: Brendan L. Thoms, et al.
Pubblicazione: (2021-07-01)